Revive Therapeutics Ltd C.RVV

Alternate Symbol(s): RVVTF

Healthcare

Revive Therapeutics Ltd. is a Canada-based life sciences company. The Company is focused on the research and development of therapeutics and diagnostics for infectious diseases, medical countermeasures, and rare disorders. It is engaged in exploring the use of Bucillamine for the potential treatment of nerve agent exposure and long COVID. The Company, through its diagnostics division, is evaluating a point-of-care in vitro diagnostic device that aids in the detection of post COVID-19 conditions or Long COVID. It also advancing the development of Psilocybin-based therapeutics through various programs. The Company's subsidiaries include Revive Therapeutics Inc. (Ontario), Revive Diagnostics Inc., and Psilocin Pharma Corp. (Ontario).

CSE:RVV - Post by User

Revive Therapeutics Ltd > Still digging but...

<< Previous

Bullboard Posts

Next >>

Comment by 1ottrunneron May 11, 2021 12:32pm

64 Views

Post# 33174156

RE:Still digging but...

No, that article is 10 years old. Although Fahy gets mention on the UCSF site Bucillamine is non-existent.

Trippedstocks wrote:
UCSF partnered and started the Global Centers for Therapeutic Innovation in 2010. That partner is Pfizer.

https://www.pfizer.com/news/press-release/press-release-detail/pfizer_launches_global_centers_for_therapeutic_innovation_a_network_of_research_partnerships_with_university_of_california_san_francisco

You think.....?